Maryland Radiation Oncologist to Receive Gold Medal Award
5/19/2004 12:12:00 PM
--------------------------------------------------------------------------------
To: National Desk
Contact: Beth Bukata of the American Society for Therapeutic Radiology and Oncology 703-227-0156 or
[email protected]
WASHINGTON, May 19 /U.S. Newswire/ -- The American Society for Therapeutic Radiology and Oncology is pleased to name Paul Wallner, D.O., one of its three 2004 Gold Medal winners. Dr. Wallner, along with Eli J. Glatstein, M.D., and Luka Milas, M.D., Ph.D., will receive his award on Monday, October 4, during ASTRO's 46th Annual Meeting being held in Atlanta on October 3-7.
"The Gold Medal designation, the highest honor ASTRO bestows, is given in recognition of distinguished accomplishments and contributions in the field of radiation oncology," said Joel E. Tepper, M.D., ASTRO Chair. "I'm very proud of our three outstanding Gold Medalists. It is a testament to the high caliber of physicians and scientists who are members of our Society."
Dr. Wallner has filled both academic and administrative positions within the field of radiation oncology since graduating from the Philadelphia College of Osteopathic Medicine. Currently, he is the Chief of the Clinical Radiation Oncology Branch, Radiation Research Program, in the Division of Cancer Treatment and Diagnosis at the National Cancer Institute in Bethesda, Md.
His contributions to the cancer community have been best exemplified by his continuous service in the sociopolitical and economic arenas. Dr. Wallner has forged valuable relationships with decision makers in top policy positions both in the private sector and the government. His superb health policy knowledge has helped educate the broader medical community on advances in radiation oncology.
Dr. Wallner's insistence on keeping radiation oncology on the forefront of scientific research and clinical collaboration in the research, development and implementation of targeted systemic radiation therapy with radiolabled monoclonal antibodies and small molecule carriers for receptors on the surface of cancer cells bodes well for the long-term relevance of both radiation oncology and ASTRO.
For a photo of Dr. Wallner, please contact Beth Bukata at 703- 227-0156 or
[email protected] For more information on radiation therapy or ASTRO's Annual Meeting, please visit
http://www.astro.org.
ASTRO is the largest radiation oncology society in the world, with more than 7,500 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment. The ASTRO Annual Meeting typically draws 9,000 healthcare professionals.
